[1] 廖穗祥,郑冠,史成龙,等. 镁合金内固定物的降解与力学强度[J].广东医学, 2016,37(1):45-49.
[2] 陶海荣,蒋垚.可降解镁合金内固定材料研究进展[J].国际骨科学杂志.2008;29(5):293-294.
[3] Jallot E, Nedelec JM, Grinault AS, et al. STEM and EDXS characterisation of physico-chemical reactions at the periphery of sol-gel derived Zn-substituted hydroxyapatites during interactions with biological fruids. colloids and surfaces B: Biointerfaces. 2005;42: 205-210.
[4] Rude RK, Singer FR, Gruber HE. Skeletal and hormonal effects of magnesium deficiency. Journal of the American College of Nutrition. 2009;28(2):131.
[5] Alexander RT, Hoenderop JG, Bindels RJ. Molecular determinants of magnesium homeostasis: insights from human disease. J Am Soc Nephrol. 2008 ;19(8):1451.
[6] Brar HS, Ball JP, Berglund IS,et al. A study of a biodegradable Mg-3Sc-3Y alloy and the effect of self-passivation on the in vitro degradation. Acta biomaterialia. 2013;9:5331-5340.
[7] Chanlalit C, shukla DR, Fitzsimmons JS, et al. Stress shielding around radial head prostheses. The Journal of hand surgery. 2012;37:2118-2125.
[8] Ghosh R, Mukherjee K, Gupta S. Bone remodelling around uncemented metallic and ceramic acetabular components. Proc Inst Mech Eng H. 2013;227:490-502.
[9] Nagels J, Stokdijk M, Rozing PM. Stress shielding and bone resorption in shoulder arthroplasty. J Shoulder Elbow Surg. 2003;12:35-39.
[10] Schmidutz F, Agarwal Y, Muller PE, et al. Stress-shielding induced bone remodeling in cementless shoulder resurfacing arthroplasty:a finite element analysis and in vivo results. J Biomech. 2014; 47:3509-3516.
[11] Kraus T, Fischerauer SF, Hanzi AC, et al. Magnesium alloys for temporary implants in osteosynthesis: in vivo studies of their degradation and interaction with bone.Acta biomaterialia. 2012; 8:1230-1238.
[12] Hartwig A. Role of magnesium in genomic stability. Mutation research. 2001;113-21.
[13] 郑玉峰,顾雪楠,李楠,等.生物可降解镁合金的发展现状与展望[J].中国材料进展,2011;30(4):30-43.
[14] Sakarat N, Pramojanee, Mattabhorn Phimphilai, et al. Chattipakorn.Possible role of insulin signaling in osteoblasts. EndocrineResearch. 2014;29(4):144-151.
[15] Nomura T, Mochida J, Okuma M, et al. Nucleus pulposus allograft retards intervertebral disc degeneration . Clin Orthop Relat Res. 2001;389:94-101.
[16] 王健,马翔宇,冯亚非,等.镁离子对成骨细胞活力和分化的促进作用及其机制研究[J].现代生物医学进展,2015, 15(15): 2836-2839.
[17] Wright HL, McCarthy HS, Middleton J, et al. RANK, RANKL and osteoprotegerin in bone biology and disease. Curr Rev Musculoskelet Med. 2009;2(1): 56-64.
[18] Witte F, Fischer J, Nellesen J, et al. In vitro and In vivo corrosion measurements of magnesium alloys. Biomaterials. 2006;27:1013-1018.
[19] Witte F, Kaese V, Haferkamp H, et al. In vivo corrosion of four magnesium alloys and the associated bone response. Biomaterials. 2005;26(17):3557-3563.
[20] Staiger MP, Pietak AM, Huadmai J, et al. Magnesium and its alloys as orthopedic biomaterials: A review. Biomaterials. 2006;27(9):1728-1734.
[21] Castellani C, Lindtner RA, Hausbrandt P, et al. Bone-implant interface strength and osseointegration: Biodegradable magnesium alloy versus standard titanium control. Acta biomaterialia. 2011;7:432-440.
[22] Vormann J.Magnesium: nutrition and metabolism. Molecular aspects of medicine. 2003;24:27-37.
[23] Saris NE, Mervaala E, Karppanen H, et al. Magnesium. An update on physiological, clinical and analytical aspects. Clin Chim Acta. 2000;294:1-26.
[24] Peng XD, Xu PZ, Chen ML, et al. Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2. Genes Dev. 2003;17:1352-1365.
[25] Ulici V, Hoenselaar KD, Agoston H, et al. The role of Akt1 in terminal stages of endochondral bone formation: angiogenesis and ossification. Bone. 2009; 45:1133-1145.
[26] Wu CM, Chen PC, Li TM, et al. Si-Wu-tang extract stimulates bone formation through PI3K/Akt/NF-kappaB signaling pathways in osteoblasts. BMC Complement Altern Med. 2013;13:277.
[27] Wu SS, Liang QH, Liu Y, et al. Omentin-1 Stimulates Human Osteoblast Proliferation through PI3K/Akt Signal Pathway.Int J Endocrinol. 2013;2013: 368970.
[28] Ghosh-Choudhury N, Abboud SL, Nishimura R, et al. Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem. 2002;277(36):33361-33368.
[29] Guntur AR, Rosen CJ. The skeleton: a multi-functional complex organ: new insights into osteoblastsand their role in bone formation: the central role of PI3Kinase. J Endocrinol. 2011;211(2):123-130.
[30] Li L, Xia Y, Wang Z, et al. Suppression of the PI3K-Akt pathway is involved in the decreased adhesion and migration of bone marrow-derived mesenchymal stem cells from non-obese diabetic mice. Cell Biol Int. 2011; 35(9):961-966.
[31] McGonnell IM, Grigoriadis AE, Lam EW, et al. A specific role for-phosphoinositide 3-kinase and AKT in osteoblasts?. Front Endocrinol (Lausanne). 2012;3:88.
[32] Wang X, Li M, Bian Z, et al. Roles of PI3K/Akt signaling pathway in regulating bone mesenchymal stem cells proliferation and differentiation. China J Osteoporosis and Bone Miner Res. 2014;3(11):1674-2591.
[33] Li FY, Chaigne-Delalande B, Kanellopoulou C, et al. Second messenger role for Mg2+ revealed by human T-cell immunodeficiency. Nature. 2011;475(7357): 471-476.
[34] Günther T. Concentration, compartmentation and metabolic function of intracellular free Mg2+. Magnes Res. 2006;19(4):225-236.
[35] Rubin H. The logic of the membrane, magnesium, mitosis( MMM) model for the regulation of animal cell proliferation. Arch Biochem Biophys. 2007;458(1):16-23.
[36] Liang D, Yang M, Guo B, et al. Zinc inhibits H (2)O (2)-induced MC3T3-E1 cells apoptosis via MAPK and PI3K/AKT pathways. Biol Trace Elem Res.2012; 148(3): 420-429.
[37] Rangaswami H, Schwappacher R, Tran T, et al. Protein kinase G and focal adhesion kinase converge on Src/Akt/beta-catenin signaling module in osteoblast mechanotransduction. J Biol Chem. 2012;287(25): 21509-21519.
[38] Adapala NS, Barbe MF, Tsygankov AY, et al. Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b. J Cell Biochem. 2014;115(7):1277-1289.
[39] Qiu L, Zhang L, Zhu L, et al. PI3K/Akt mediates expression of TNF-alpha mRNA and activation of NF-kappaB in calyculin A-treated primary osteoblasts. Oral Dis. 2008;14(8):727-733.
[40] 陈亚辉,龚忠勒,崔燎.PI3K/Akt信号通路在骨质疏松病理过程中的作用[J].中国骨质疏松杂志,2015;21(3);356-360.
[41] Hay E, Nouraud A, Marie PJ. N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling.PLOS ONE. 2009;4(12):e8284.
[42] Rangaswami H, Schwappacher R, Tran T, et al. Protein kinase G and focal adhesion kinase converge on Src/Akt/beta-catenin signaling module in osteoblast mechanotransduction. J Biol Chem. 2012;287(25): 21509-21519.
[43] O’ Brien EA, Williams JH, Marshall MJ. Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane. Bone. 2001; 28(2):208-214.
[44] Bae YJ, Kim MH. Calcium and magnesium supplementation improves serum OPG/RANKL in calcium-deficient ovariectomized rats. Calcified tissue International. 2010;87(4):365-372.
[45] Schoppet M, Preissner KT, Hofbauer LC. RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. Arterioscler Thromb Vasc Biol. 2002;22(4):549-553.
[46] Kulkarni RN, Bakker AD, Everts V, et al. Inhibition of osteoclastogenesis by mechanically loaded osteocytes: involvement of MEPE. Calcif Tissue Int. 2010; 87(5): 461-468.
[47] Zhang L, Yang C, He S. Recent advances in the study of regulation effect of TRPM family in cellular calcium / magnesium homeostasis. Basic Clin Med. 2013;3(33): 371-373.
[48] Walder RY, Yang B, Stokes JB, et al. Mice defective in Trpm6 show embryonic mortality and neural tube defects . Hum Mol Genet. 2009;18:4367-4375.
[49] Bates-Withers C, Sah R, Clapham DE. TRPM7, the Mg(2+) inhibited channel and kinase. Advances in experimental medicine and biology. Adv Exp Med Biol. 2011;704:173-183.
[50] Penner R, Fleig A. The Mg2+ and Mg2+-nucleotide- regulated channel-kinase TRPM7. Transient Receptor Potential(TRP)Channels. 2007;313-328.
[51] Schmitz C, Perraud A-L, Johnson CO, et al. Regulation of Vertebrate Cellular Mg2+ Homeostasis by TRPM7. Cell. 2003;114(2):191-200.
[52] Abed E, Moreau R. Importance of melastatin-like transient receptor potential 7 and magnesium in the stimulation of osteoblast proliferation and migration by platelet-derived growth factor. American Journal of Physiology-Cell Physiology. 2009;297(2): C360-C368.
[53] Abed E, Moreau R. Importance of melastatin-like transient receptor potential 7 and cations (magnesium,calcium) in human osteoblast-like cell proliferation.Cell proliferation. 2007;40(6):849-865.
[54] Martineau C, Abed E, Medina G, et al. Involvement of transient receptor potential melastatin-related7(TRPM7)channels in cadmium uptake and cytotoxicity in MC3T3-E1 osteoblasts. Toxicol Lett. 2010;199(3):357-363.
[55] Liu S, Guo J, Chen Sh, et al. TRPM Ion Channels and Human Diseases. rogress in Modern Biomedicine. 2015;34(15):6792-6796.
[56] Pandur P, Maurus D, Kuhl M. Increasingly complex: newplayers enter the Wnt signaling network. Bio Essays. 2002;24(10):881-884.
[57] Logan CY, Nusse R. The Wnt signaling pathway in developmentand disease. Annu Rev Cell Dev Biol. 2004;20:781-810.
[58] Mulholland DJ, Dedhar S, Coetzee GA,et al. Interaction of Nuclear Receptors with the Wnt/β-Catenin /Tcf Signaling Axis: Wnt You Like to Knew? Endocr Rev. 2005;26(7):898-915.
[59] Maruyama Z, Yoshida CA,Furuichi T, et al. Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency. J Dev dyn. 2007;236(7): 1876-1890.
[60] Wang Z, Guo J. Mechanical induction of BMP-7 in osteocyte blocks glucocorticoid-induced apoptosis through PI3K/AKT /GSK3beta pathway. Cell Biochem Biophys. 2013;67(2):567-574.
[61] Dufour C, Holy X, Marie PJ. Transforming growth factor-beta prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signaling. Am J Physiol Endocrinol Metab. 2008;294(4):E794-801.
[62] Weglicki WB. Hypomagnesemia and inflammation: clinical and basic aspects. Annu Rev Nutr. 2012;32: 55-71.
[63] Rosanoff A, Weaver CM, Rude RK. Suboptimal magnesium status in the United States: are the health consequences underestimated? Nutr Rev. 2012;70(3): 153-164.
[64] Riond JL, Hartmann P, Steiner P, et al. Long-term excessive magnesium supplementation is deleterious whereas suboptimal supply is beneficial for bones in rats.Magnes Res. 2000;13(4): 249-264.
[65] Yun Y, Dong Z, Tan Z, et al. Development of an electrode cell impedance method to measure osteoblast cell activity in magnesium-conditioned media. Anal Bioanal Chem.2010;396:3009-3015.
[66] Staiger MP, Pietak AM, Huadmai J, et al. Magnesium and its alloys as orthopedic biomaterials: a review. Biomaterials. 2006;27:1728-1734.
[67] Yuan G, Zhang X, Niu G, et al. Research progress of new type of degradable biomedical magnesium alloys JDBM.The Chinese Journal of Nonferrous Metal. 2011;21(10):2476-2480.
[68] Yuan G, Zhang J, Ding W. Research Progress of Mg-Based Alloys as Degradable Biomedical Material. Materials China. 2011;30(2):44-50.
[69] [Wang J, Tang J, Zhang P, et al. Surface modification of magnesium alloys developed for bioabsorbable orthopedic implants: a general review. J Biomed Mater Res B Appl Biomaterial. 2012;100 (6):1691-1701. |